Number of the records: 1  

CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers

  1. TitleCXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers
    Author Fridrichová Ivana 1958 SAVEXONK - Ústav experimentálnej onkológie SAV    SCOPUS    RID    ORCID
    Co-authors Smolková Božena 1968- SAVEXONK - Ústav experimentálnej onkológie SAV    SCOPUS    RID    ORCID

    Horváthová Kajabová Viera 1985- SAVEXONK - Ústav experimentálnej onkológie SAV    ORCID

    Zmetáková Iveta 1979- SAVEXONK - Ústav experimentálnej onkológie SAV

    Krivulčík Tomáš 1982- SAVEXONK - Ústav experimentálnej onkológie SAV

    Mego Michal

    Čierna Zuzana

    Boháč Martin

    Repiská V.

    Danihel Ľudovít

    Co-authors Karaba Marián Benca Juraj Pindak Daniel
    Source document Translational research : The Journal of Laboratory and Clinical Medicine. Vol. 165, no. 6 (2015) p. 717-730
    Languageeng - English
    CountryUS - United States of America
    Document kindrozpis článkov z periodík (rbx)
    CitationsFANTONY, Joseph J. - ABERN, Michael R. - GOPALAKRISHNA, Ajay - OWUSU, Richmond - TAY, Kae Jack - LANCE, Raymond S. - INMAN, Brant A. Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer. In UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. ISSN 1078-1439, 2015, vol. 33, no. 9, pp.
    ZHOU, Dan - TANG, Weiwei - WANG, Wenyi - PAN, Xiaoyan - AN, Han-Xiang - ZHANG, Yun. Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies. In PEERJ. ISSN 2167-8359, 2016, vol. 4, no., pp.
    WANG, Songping - CLARKE, Pamela A. G. - DAVIS, Roderick - MUMUNI, Salma - KWABI-ADDO, Bernard. Sex steroid-induced DNA methylation changes and inflammation response in prostate cancer. In CYTOKINE. ISSN 1043-4666, 2016, vol. 86, no., pp. 110.
    WANG, Zhidong - SUN, Jian - FENG, Yeqian - TIAN, Xiaocai - WANG, Bin - ZHOU, Yong. Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell. In TUMOR BIOLOGY. ISSN 1010-4283, 2016, vol. 37, no. 7, pp. 8515.
    GIROTRA, Shantanu - YEGHIAZARYAN, Kristina - GOLUBNITSCHAJA, Olga. Potential biomarker panels in overall breast cancer management: advancements by multilevel diagnostics. In PERSONALIZED MEDICINE. ISSN 1741-0541, 2016, vol. 13, no. 5, pp. 469.
    FU, Zhi Chao - WANG, Feng Mei - CAI, Jian Ming. Gene expression changes in residual advanced cervical cancer after radiotherapy: Indicators of poor prognosis and radioresistance? In Medical Science Monitor. ISSN 12341010, 2015-05-05, 21, pp. 1276-1287.
    KING, Jeronay - MIR, Hina - SINGH, Shailesh. Association of Cytokines and Chemokines in Pathogenesis of Breast Cancer. In APPROACHES TO UNDERSTANDING BREAST CANCER. ISSN 1877-1173, 2017, vol. 151, no., pp. 113-136.
    WILSON, Gillian J. - HEWIT, Kay D. - PALLAS, Kenneth J. - CAIRNEY, Claire J. - LEE, Kit M. - HANSELL, Christopher A. - STEIN, Torsten - GRAHAM, Gerard J. Atypical chemokine receptor ACKR2 controls branching morphogenesis in the developing mammary gland. In DEVELOPMENT. ISSN 0950-1991, 2017, vol. 144, no. 1, pp. 74-82.
    QIAN, Dong - LU, Zipeng - XU, Qingcheng - WU, Pengfei - TIAN, Lei - ZHAO, Liangtao - CAI, Baobao - YIN, Jie - WU, Yang - STAVELEY-O'CARROLL, Kevin F. - JIANG, Kuirong - MIAO, Yi - LI, Guangfu. Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis. In CANCER LETTERS. ISSN 0304-3835, 2017, vol. 397, no., pp. 43-51.
    XU, Y. L. - YAO, R. - LI, J. - ZHOU, Y. D. - MAO, F. - PAN, B. - SUN, Q. FOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancer. In CANCER CHEMOTHERAPY AND PHARMACOLOGY. ISSN 0344-5704, 2017, vol. 79, no. 6, pp. 1205-1213.
    YEO, Chang Dong - KANG, Nahyeon - CHOI, Su Yeon - KIM, Bit Na - PARK, Chan Kwon - KIM, Jin Woo - KIM, Young Kyoon - KIM, Seung Joon. The role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: a possible link to epigenetic regulation. In KOREAN JOURNAL OF INTERNAL MEDICINE. ISSN 1226-3303, 2017, vol. 32, no. 4, pp. 589-599.
    ZHANG, Sijia - WANG, Yihan - CHEN, Meijun - SUN, Lulu - HAN, Jun - ELENA, V. Kazakova - QIAO, Hong. CXCL12 methylation-mediated epigenetic regulation of gene expression in papillary thyroid carcinoma. In SCIENTIFIC REPORTS. ISSN 2045-2322, 2017, vol. 7, no., pp.
    MA, Ruiqiong - TANG, Zhijian - SUN, Kunkun - YE, Xue - CHENG, Hongyan - CHANG, Xiaohong - CUI, Heng. Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival. In PATHOLOGY RESEARCH AND PRACTICE. ISSN 0344-0338, 2018, vol. 214, no. 8, pp. 1115-1122.
    HAMADNEH, Lama - AL-MAJAWLEH, May - JARRAR, Yazun - SHRAIM, Sawsan - HASAN, Mariam - ABU-IRMAILEH, Basha'er. Culturing conditions highly affect DNA methylation and gene expression levels in MCF7 breast cancer cell line. In IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL. ISSN 1071-2690, 2018, vol. 54, no. 5, pp. 331-334.
    GUAN, Zhong - YU, Haixin - CUK, Katarina - ZHANG, Yan - BRENNER, Hermann. Whole-Blood DNA Methylation Markers in Early Detection of Breast Cancer: A Systematic Literature Review. In CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. ISSN 1055-9965, 2019, vol. 28, no. 3, pp. 496-505.
    ZHOU, Weiqiang - GUO, Shanchun - LIU, Mingli - BUROW, Matthew E. - WANG, Guangdi. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy. In CURRENT MEDICINAL CHEMISTRY. ISSN 0929-8673, 2019, vol. 26, no. 17, pp. 3026-3041.
    MOUSAVI, Ashraf. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy. In IMMUNOLOGY LETTERS. ISSN 0165-2478, 2020, vol. 217, no., pp. 91-115.
    CHEN, C. - ZHAO, J. - LIU, J.N. - SUN, C.Y. Mechanism and Role of the Neuropeptide LGI1 Receptor ADAM23 in Regulating Biomarkers of Ferroptosis and Progression of Esophageal Cancer. In DISEASE MARKERS. ISSN 0278-0240, DEC 30 2021, vol. 2021.
    PORTELLA, L. - BELLO, A.M. - SCALA, S. CXCL12 Signaling in the Tumor Microenvironment. In TUMOR MICROENVIRONMENT: THE ROLE OF CHEMOKINES - PT B. ISSN 0065-2598, 2021, vol. 1302, p. 51-70.
    HOU, J. - WEN, X.Y. - LU, Z.Q. - WU, G.Q. - YANG, G. - TANG, C. - QU, G.Y. - XU, Y. A novel T-cell proliferation-associated regulator signature pre-operatively predicted the prognostic of bladder cancer. In FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, SEP 23 2022, vol. 13. Dostupné na: https://doi.org/10.3389/fimmu.2022.970949.
    HOZHABRI, H. - MOGHADDAM, M.M. - MOGHADDAM, M.M. - MOHAMMADIAN, A. A comprehensive bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast cancer. In SCIENTIFIC REPORTS. ISSN 2045-2322, JUN 20 2022, vol. 12, no. 1. Dostupné na: https://doi.org/10.1038/s41598-022-14610-2.
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2015
    Registered inWOS
    Registered inSCOPUS
    Registered inCCC
    DOI 10.1016/j.trsl.2014.12.006
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    201520145.030Q11.927Q1
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.